Global Topical Pain Relief Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Topical Pain Relief market report explains the definition, types, applications, major countries, and major players of the Topical Pain Relief market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer Inc

    • Novartis AG

    • Nestle SA

    • Johnson & Johnson

    • AdvaCare Pharma

    • Sanofi SA

    • Sun Pharmaceutical Industries Ltd

    • Reckitt Benckiser Group Plc

    • Topical BioMedics

    • GlaxoSmithKline Plc

    By Type:

    • Non-Opioids

    • Opioids

    By End-User:

    • Pharmacies & Drug Stores

    • e-Commerce

    • Retail & Grocery Stores

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Topical Pain Relief Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Topical Pain Relief Outlook to 2028- Original Forecasts

    • 2.2 Topical Pain Relief Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Topical Pain Relief Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Topical Pain Relief Market- Recent Developments

    • 6.1 Topical Pain Relief Market News and Developments

    • 6.2 Topical Pain Relief Market Deals Landscape

    7 Topical Pain Relief Raw Materials and Cost Structure Analysis

    • 7.1 Topical Pain Relief Key Raw Materials

    • 7.2 Topical Pain Relief Price Trend of Key Raw Materials

    • 7.3 Topical Pain Relief Key Suppliers of Raw Materials

    • 7.4 Topical Pain Relief Market Concentration Rate of Raw Materials

    • 7.5 Topical Pain Relief Cost Structure Analysis

      • 7.5.1 Topical Pain Relief Raw Materials Analysis

      • 7.5.2 Topical Pain Relief Labor Cost Analysis

      • 7.5.3 Topical Pain Relief Manufacturing Expenses Analysis

    8 Global Topical Pain Relief Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Topical Pain Relief Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Topical Pain Relief Export by Region (Top 10 Countries) (2017-2028)

    9 Global Topical Pain Relief Market Outlook by Types and Applications to 2022

    • 9.1 Global Topical Pain Relief Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Non-Opioids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Opioids Consumption and Growth Rate (2017-2022)

    • 9.2 Global Topical Pain Relief Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmacies & Drug Stores Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global e-Commerce Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail & Grocery Stores Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Topical Pain Relief Market Analysis and Outlook till 2022

    • 10.1 Global Topical Pain Relief Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Topical Pain Relief Consumption (2017-2022)

      • 10.2.2 Canada Topical Pain Relief Consumption (2017-2022)

      • 10.2.3 Mexico Topical Pain Relief Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Topical Pain Relief Consumption (2017-2022)

      • 10.3.2 UK Topical Pain Relief Consumption (2017-2022)

      • 10.3.3 Spain Topical Pain Relief Consumption (2017-2022)

      • 10.3.4 Belgium Topical Pain Relief Consumption (2017-2022)

      • 10.3.5 France Topical Pain Relief Consumption (2017-2022)

      • 10.3.6 Italy Topical Pain Relief Consumption (2017-2022)

      • 10.3.7 Denmark Topical Pain Relief Consumption (2017-2022)

      • 10.3.8 Finland Topical Pain Relief Consumption (2017-2022)

      • 10.3.9 Norway Topical Pain Relief Consumption (2017-2022)

      • 10.3.10 Sweden Topical Pain Relief Consumption (2017-2022)

      • 10.3.11 Poland Topical Pain Relief Consumption (2017-2022)

      • 10.3.12 Russia Topical Pain Relief Consumption (2017-2022)

      • 10.3.13 Turkey Topical Pain Relief Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Topical Pain Relief Consumption (2017-2022)

      • 10.4.2 Japan Topical Pain Relief Consumption (2017-2022)

      • 10.4.3 India Topical Pain Relief Consumption (2017-2022)

      • 10.4.4 South Korea Topical Pain Relief Consumption (2017-2022)

      • 10.4.5 Pakistan Topical Pain Relief Consumption (2017-2022)

      • 10.4.6 Bangladesh Topical Pain Relief Consumption (2017-2022)

      • 10.4.7 Indonesia Topical Pain Relief Consumption (2017-2022)

      • 10.4.8 Thailand Topical Pain Relief Consumption (2017-2022)

      • 10.4.9 Singapore Topical Pain Relief Consumption (2017-2022)

      • 10.4.10 Malaysia Topical Pain Relief Consumption (2017-2022)

      • 10.4.11 Philippines Topical Pain Relief Consumption (2017-2022)

      • 10.4.12 Vietnam Topical Pain Relief Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Topical Pain Relief Consumption (2017-2022)

      • 10.5.2 Colombia Topical Pain Relief Consumption (2017-2022)

      • 10.5.3 Chile Topical Pain Relief Consumption (2017-2022)

      • 10.5.4 Argentina Topical Pain Relief Consumption (2017-2022)

      • 10.5.5 Venezuela Topical Pain Relief Consumption (2017-2022)

      • 10.5.6 Peru Topical Pain Relief Consumption (2017-2022)

      • 10.5.7 Puerto Rico Topical Pain Relief Consumption (2017-2022)

      • 10.5.8 Ecuador Topical Pain Relief Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Topical Pain Relief Consumption (2017-2022)

      • 10.6.2 Kuwait Topical Pain Relief Consumption (2017-2022)

      • 10.6.3 Oman Topical Pain Relief Consumption (2017-2022)

      • 10.6.4 Qatar Topical Pain Relief Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Topical Pain Relief Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Topical Pain Relief Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Topical Pain Relief Consumption (2017-2022)

      • 10.7.2 South Africa Topical Pain Relief Consumption (2017-2022)

      • 10.7.3 Egypt Topical Pain Relief Consumption (2017-2022)

      • 10.7.4 Algeria Topical Pain Relief Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Topical Pain Relief Consumption (2017-2022)

      • 10.8.2 New Zealand Topical Pain Relief Consumption (2017-2022)

    11 Global Topical Pain Relief Competitive Analysis

    • 11.1 Pfizer Inc

      • 11.1.1 Pfizer Inc Company Details

      • 11.1.2 Pfizer Inc Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer Inc Topical Pain Relief Main Business and Markets Served

      • 11.1.4 Pfizer Inc Topical Pain Relief Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novartis AG

      • 11.2.1 Novartis AG Company Details

      • 11.2.2 Novartis AG Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novartis AG Topical Pain Relief Main Business and Markets Served

      • 11.2.4 Novartis AG Topical Pain Relief Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Nestle SA

      • 11.3.1 Nestle SA Company Details

      • 11.3.2 Nestle SA Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Nestle SA Topical Pain Relief Main Business and Markets Served

      • 11.3.4 Nestle SA Topical Pain Relief Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Johnson & Johnson

      • 11.4.1 Johnson & Johnson Company Details

      • 11.4.2 Johnson & Johnson Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Johnson & Johnson Topical Pain Relief Main Business and Markets Served

      • 11.4.4 Johnson & Johnson Topical Pain Relief Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 AdvaCare Pharma

      • 11.5.1 AdvaCare Pharma Company Details

      • 11.5.2 AdvaCare Pharma Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 AdvaCare Pharma Topical Pain Relief Main Business and Markets Served

      • 11.5.4 AdvaCare Pharma Topical Pain Relief Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sanofi SA

      • 11.6.1 Sanofi SA Company Details

      • 11.6.2 Sanofi SA Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sanofi SA Topical Pain Relief Main Business and Markets Served

      • 11.6.4 Sanofi SA Topical Pain Relief Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sun Pharmaceutical Industries Ltd

      • 11.7.1 Sun Pharmaceutical Industries Ltd Company Details

      • 11.7.2 Sun Pharmaceutical Industries Ltd Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sun Pharmaceutical Industries Ltd Topical Pain Relief Main Business and Markets Served

      • 11.7.4 Sun Pharmaceutical Industries Ltd Topical Pain Relief Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Reckitt Benckiser Group Plc

      • 11.8.1 Reckitt Benckiser Group Plc Company Details

      • 11.8.2 Reckitt Benckiser Group Plc Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Reckitt Benckiser Group Plc Topical Pain Relief Main Business and Markets Served

      • 11.8.4 Reckitt Benckiser Group Plc Topical Pain Relief Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Topical BioMedics

      • 11.9.1 Topical BioMedics Company Details

      • 11.9.2 Topical BioMedics Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Topical BioMedics Topical Pain Relief Main Business and Markets Served

      • 11.9.4 Topical BioMedics Topical Pain Relief Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 GlaxoSmithKline Plc

      • 11.10.1 GlaxoSmithKline Plc Company Details

      • 11.10.2 GlaxoSmithKline Plc Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 GlaxoSmithKline Plc Topical Pain Relief Main Business and Markets Served

      • 11.10.4 GlaxoSmithKline Plc Topical Pain Relief Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Topical Pain Relief Market Outlook by Types and Applications to 2028

    • 12.1 Global Topical Pain Relief Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Non-Opioids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Opioids Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Topical Pain Relief Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharmacies & Drug Stores Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global e-Commerce Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Retail & Grocery Stores Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Topical Pain Relief Market Analysis and Outlook to 2028

    • 13.1 Global Topical Pain Relief Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.2.2 Canada Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Topical Pain Relief Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.2 UK Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.3 Spain Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.5 France Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.6 Italy Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.8 Finland Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.9 Norway Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.11 Poland Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.12 Russia Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Topical Pain Relief Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.2 Japan Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.3 India Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Topical Pain Relief Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.5.3 Chile Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.5.6 Peru Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Topical Pain Relief Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.6.3 Oman Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Topical Pain Relief Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Topical Pain Relief Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Topical Pain Relief Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Topical Pain Relief Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Topical Pain Relief

    • Figure of Topical Pain Relief Picture

    • Table Global Topical Pain Relief Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Topical Pain Relief Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Non-Opioids Consumption and Growth Rate (2017-2022)

    • Figure Global Opioids Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacies & Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global e-Commerce Consumption and Growth Rate (2017-2022)

    • Figure Global Retail & Grocery Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Topical Pain Relief Consumption by Country (2017-2022)

    • Table North America Topical Pain Relief Consumption by Country (2017-2022)

    • Figure United States Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Canada Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Mexico Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Table Europe Topical Pain Relief Consumption by Country (2017-2022)

    • Figure Germany Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure UK Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Spain Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Belgium Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure France Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Italy Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Denmark Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Finland Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Norway Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Sweden Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Poland Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Russia Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Turkey Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Table APAC Topical Pain Relief Consumption by Country (2017-2022)

    • Figure China Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Japan Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure India Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure South Korea Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Thailand Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Singapore Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Philippines Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Table South America Topical Pain Relief Consumption by Country (2017-2022)

    • Figure Brazil Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Colombia Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Chile Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Argentina Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Peru Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Table GCC Topical Pain Relief Consumption by Country (2017-2022)

    • Figure Bahrain Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Oman Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Qatar Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Table Africa Topical Pain Relief Consumption by Country (2017-2022)

    • Figure Nigeria Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure South Africa Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Egypt Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure Algeria Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Table Oceania Topical Pain Relief Consumption by Country (2017-2022)

    • Figure Australia Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Topical Pain Relief Consumption and Growth Rate (2017-2022)

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Topical Pain Relief Main Business and Markets Served

    • Table Pfizer Inc Topical Pain Relief Product Portfolio

    • Table Novartis AG Company Details

    • Table Novartis AG Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Topical Pain Relief Main Business and Markets Served

    • Table Novartis AG Topical Pain Relief Product Portfolio

    • Table Nestle SA Company Details

    • Table Nestle SA Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nestle SA Topical Pain Relief Main Business and Markets Served

    • Table Nestle SA Topical Pain Relief Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Topical Pain Relief Main Business and Markets Served

    • Table Johnson & Johnson Topical Pain Relief Product Portfolio

    • Table AdvaCare Pharma Company Details

    • Table AdvaCare Pharma Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table AdvaCare Pharma Topical Pain Relief Main Business and Markets Served

    • Table AdvaCare Pharma Topical Pain Relief Product Portfolio

    • Table Sanofi SA Company Details

    • Table Sanofi SA Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Topical Pain Relief Main Business and Markets Served

    • Table Sanofi SA Topical Pain Relief Product Portfolio

    • Table Sun Pharmaceutical Industries Ltd Company Details

    • Table Sun Pharmaceutical Industries Ltd Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Ltd Topical Pain Relief Main Business and Markets Served

    • Table Sun Pharmaceutical Industries Ltd Topical Pain Relief Product Portfolio

    • Table Reckitt Benckiser Group Plc Company Details

    • Table Reckitt Benckiser Group Plc Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reckitt Benckiser Group Plc Topical Pain Relief Main Business and Markets Served

    • Table Reckitt Benckiser Group Plc Topical Pain Relief Product Portfolio

    • Table Topical BioMedics Company Details

    • Table Topical BioMedics Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table Topical BioMedics Topical Pain Relief Main Business and Markets Served

    • Table Topical BioMedics Topical Pain Relief Product Portfolio

    • Table GlaxoSmithKline Plc Company Details

    • Table GlaxoSmithKline Plc Topical Pain Relief Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Topical Pain Relief Main Business and Markets Served

    • Table GlaxoSmithKline Plc Topical Pain Relief Product Portfolio

    • Figure Global Non-Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacies & Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global e-Commerce Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail & Grocery Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Topical Pain Relief Consumption Forecast by Country (2022-2028)

    • Table North America Topical Pain Relief Consumption Forecast by Country (2022-2028)

    • Figure United States Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Topical Pain Relief Consumption Forecast by Country (2022-2028)

    • Figure Germany Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Topical Pain Relief Consumption Forecast by Country (2022-2028)

    • Figure China Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Topical Pain Relief Consumption Forecast by Country (2022-2028)

    • Figure Brazil Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Topical Pain Relief Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Topical Pain Relief Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Topical Pain Relief Consumption Forecast by Country (2022-2028)

    • Figure Australia Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Topical Pain Relief Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.